Related Experiment Video
Updated: Aug 10, 2025

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
Mixed urinary incontinence: Are there effective treatments?
Xavier Game1, Roger Dmochowski2, Dudley Robinson3
1Department of Urology, CHU Rangueil, Toulouse, France.
Effective treatments for mixed urinary incontinence (MUI) are currently lacking. Standard and emerging therapies often focus on a predominant symptom, leaving many MUI patients undertreated.
Area of Science:
- Urology
- Gynecology
- Geriatrics
Background:
- Mixed urinary incontinence (MUI) involves both stress and urgency urinary incontinence (SUI and UUI) symptoms.
- Current treatment guidelines recommend addressing the predominant symptom first.
- This approach may lead to suboptimal management for patients with combined symptoms.
Purpose of the Study:
- To debate the availability of effective treatments for mixed urinary incontinence (MUI).
- To review standard and emerging treatments for SUI and UUI in the context of MUI.
- To assess how well current treatments meet the needs of patients with MUI.
Main Methods:
- Review of standard treatments including lifestyle changes, pelvic floor exercises, pharmacological agents, and surgery.
- Examination of emerging treatments, particularly novel pharmacological agents.
- Analysis of treatment guidelines and clinical trial criteria for SUI and UUI.
Main Results:
- Standard treatments for MUI often focus on the predominant symptom, with surgery being standard for SUI and pharmacological agents for UUI.
- Emerging pharmacological treatments primarily target UUI, frequently excluding patients with SUI or stress-predominant MUI from trials.
- This selective focus results in a gap in effective therapeutic options for many MUI patients.
Conclusions:
- Current standard and emerging treatments are insufficient for effectively managing mixed urinary incontinence (MUI).
- A need exists for treatments that address both stress and urgency components of MUI simultaneously.
- Development of agents with dual mechanisms of action is proposed as an ideal future direction.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi III: Medical Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS

